Information on Abzena’s Response to COVID-19
The COVID-19 pandemic is a global public health issue of concern to all. Read more to find the latest on our detailed efforts to ensure the health and well-being of our employees, as well as our business continuity plan for our partner clients at our three sites in the US and UK.Read More
Sonnet BioTherapeutics selects Abzena as clinical stage manufacturing partner
The clinical stage biopharmaceutical company developing innovative targeted biologic drugs, announced it has selected Abzena as its manufacturing partner for SON-1010, an IL-12-FHAB cytokineRead More
Technologies and Solutions
Abzena provides proprietary technologies and complementary solutions to organisations involved in the development of biopharmaceutical products.
Latest News and Events
Abzena presents its latest research and exhibits at events all over the world.
Find out where we are next and our latest news below.
Abzena invests $60m into cGMP manufacturing capacity
WEBINAR – Pre-formulation: De-risking Development Programs to Ensure a Successful IND Filing
8 October 2020
Abzena appoints Giovanni Escobar as SVP and Site Head of Bristol, Pennsylvania Operations
Festival of Biologics 2020
2 November 2020
Resources and Downloads
Find our latest videos, brochures and fact sheets in our resources section.
Download our Brochure
Technology & Solutions BrochureDownload File
Antibody drug conjugates of cleavable amino-alkyl and aryl maytansinoids
Natural products have been used for many medicinal purposes for centuries. Antibody drug conjugates (ADCs)…Read More
Cell Line Development Lab Tour
Abzena has over 10 years experience in Cell Line Development for customers and has completed…